Biovie Inc 's ROA from the fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Biovie Inc 's ROA in the fourth quarter of 2026?
Biovie Inc recorded a cumulative net loss of $-22 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on assets (ROA) of -52.84%.

However, within the Healthcare sector 755 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4224, from total ROA ranking in the third quarter of 2026 at 4830.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter	(Jun 30 2025) IV. Quarter
Y / Y Total Assets Change	369.32 %	-27.93 %	-14.46 %	26.28 %	-14.46 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-22	-20	-17	-18	-18
Return On Assets (TTM)	-52.84 %	-91.09 %	-73.99 %	-75.5 %	-76.01 %
BIVI's Total Ranking	# 4224	# 4830	# 4240	# 4307	# 4411
Total Assets (TTM) in million	101	18	22	27	22
Seq. Total Assets Change	477.77 %	-18.77 %	-19.6 %	24.38 %	-11.28 %
Seq. Net Income Change	-	-	-	-	-

BIVI's 5 Years Annual ROA >> Back to BIVI Management Effectiveness >> Compare BIVI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 351
Sector	# 756
Overall	# 4254

Return On Assets Statistics
High	Average	Low
597.45 %	-95.21 %	-714.13 %
(Jun 30 2021)		(Jun 30 2020)

Financial Statements
Biovie Inc 's Assets	$ 101 million	BIVI's Balance sheet
Biovie Inc 's Income	$ -6 million	Quarterly BIVI's Income Statement
BIVI's Income by Division		See BIVI's Income by Division

Annual Return On Assets	(Jun 30 2026) FY 2026	(Jun 30 2025) FY 2025	(Jun 30 2024) FY 2024	(Jun 30 2023) FY 2023	(Jun 30 2022) FY 2022
Y / Y Total Assets Change	369.32 %	-14.46 %	-28.19 %	74.52 %	232.65 %
Total Assets in million	101	22	25	35	20
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-22	-18	-32	-50	-26
Annual Return On Assets	-21.81 %	-81.36 %	-127.42 %	-143.16 %	-129.68 %

BIVI's 5 Years Annual ROA >> Back to BIVI Management Effectiveness >> Compare BIVI ROA to its Competitors

More Return On Assets Ratios
BIVI's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BIVI's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BIVI's Competitors
Subscribers only: Roa for Biovie Inc 's Suppliers
Subscribers only: Return On Assets for BIVI's Customers

You may also want to know
BIVI's Roi	BIVI's Inventory Turnover Ratio	BIVI's Growth Rates	BIVI's Dividend Comparisons
	BIVI's Profitability Ratios	BIVI's Asset Turnover Ratio	BIVI's Dividend Growth
BIVI's Roe	BIVI's Valuation Ratios	BIVI's Financial Strength Ratios	BIVI's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-02T19:07:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.